# TRT and hormone therapy programs, under your brand

Source: https://myorbithealth.com/solutions/hormone-therapy-trt

MyOrbitHealth is the TRT telehealth platform behind branded men's health and hormone programs. You own the brand, the patients, the pricing and the checkout. MyOrbitHealth supplies the parts an online TRT clinic cannot legally run on its own: 2,400+ board-certified providers licensed across all 50 states, EPCS e-prescribing with two-factor identity proofing for Schedule III testosterone, a LegitScript-certified pharmacy network that includes 503A compounding and retail pharmacies, and Orbit Labs for the two morning testosterone draws that AUA guidance expects before a diagnosis. The same stack runs HRT for women, including menopause programs built on estradiol and progesterone, with the follow-up cadence a hormone program actually needs. Providers respond in under six minutes on average during business hours, coverage is 24 hours, and every contract carries HIPAA and a BAA. Commercially there is a flat platform fee scoped at onboarding, 0% medication markup, no revenue share, no exit fee and month-to-month terms after onboarding. Programs typically go live in days. This page is general information, not legal or medical advice, and regulatory points are stated as of September 2026.

## Who runs what

A hormone program has two halves: the brand and the clinic. You run the brand. MyOrbitHealth runs the clinical, pharmacy, lab and compliance infrastructure so the program operates the way a licensed practice does. The split below is the one we put in every contract.

- **Brand, marketing and pricing:** You: own the brand, the storefront design, ad spend, membership pricing and the patient relationship. / MyOrbitHealth: supplies the branded storefront, checkout and subscriptions, and the native iOS and Android app, with no MyOrbitHealth logo in front of the patient.
- **Intake and eligibility:** You: choose which programs to offer (TRT, HRT, menopause, both) and which states to launch first. / MyOrbitHealth: runs Orbit Intake with hormone-specific questionnaires, identity verification, state routing and the screening questions a provider needs before an initial visit.
- **Baseline and recheck labs:** You: decide which panels appear on the storefront and whether patients can self-order from the lab catalog. / MyOrbitHealth: Orbit Labs issues provider-ordered requisitions, offers Quest or Labcorp walk-in, Tasso at-home kits or mobile phlebotomy, and routes results back to the ordering provider.
- **Diagnosis and prescribing:** You: never touch a clinical decision. / MyOrbitHealth: a provider licensed in the patient's state reviews symptoms and two morning testosterone values, decides whether treatment is appropriate, and prescribes through OrbitRx with EPCS where a controlled substance is involved.
- **Pharmacy and fulfillment:** You: set the product menu (injectable cypionate, gels, pellets referrals, estradiol, progesterone, ancillaries) with your medical director. / MyOrbitHealth: routes each prescription via Surescripts to a LegitScript-certified 503A compounding or retail pharmacy, with cold chain where the product requires it.
- **Follow-up and monitoring:** You: see adherence, refill and recheck status in OrbitOS and run retention. / MyOrbitHealth: providers schedule recheck labs, adjust dosing, document blood pressure and hematocrit follow-up, and handle patient messages inside the portal.
- **Compliance and credentialing:** You: sign the contract and keep your marketing claims honest. / MyOrbitHealth: NCQA-standard primary-source credentialing with monthly OIG and SAM screening, SOC 2 Type II, HITRUST-aligned controls, HIPAA plus a BAA in every contract, and managed LegitScript certification for your brand.

## What a TRT or HRT program requires, clinically and legally

Testosterone is a Schedule III controlled substance under federal law, which puts an online TRT clinic in a different category from a GLP-1 or hair loss program. The points below reflect the rules as we understand them as of September 2026. They are general information, not legal or medical advice, and your own counsel should confirm them for your states and products.

- **EPCS and the DEA telemedicine flexibilities** — Prescribing a Schedule III product electronically requires an EPCS-capable system with two-factor authentication and identity-proofed prescribers. Separately, the DEA and HHS extended the COVID-era telemedicine flexibilities a fourth time, through December 31, 2026, which lets DEA-registered practitioners prescribe Schedule II through V medications by audio-video telemedicine without a prior in-person exam. The DEA has said it intends to publish a final rule before that date. Any program launched today should be built so it can add an in-person or special-registration step if the final rule requires one.
- **Two labs before a diagnosis** — The American Urological Association guideline defines testosterone deficiency as a total testosterone consistently below 300 ng/dL on at least two early-morning measurements taken on separate occasions, paired with symptoms or signs. A program that prescribes off a single value, or off symptoms alone, is out of step with the guideline and exposed on review. Your medical director may set a stricter protocol, but two morning draws is the floor we build into the intake flow.
- **State licensure and telehealth practice standards** — The prescribing provider must hold a license in the state where the patient is located at the time of the visit, and several states impose their own telehealth rules for controlled substances, including video requirements, additional PDMP checks or in-person visit expectations. Coverage across all 50 states means the network can route a visit to a provider licensed for that patient, and OrbitOS applies state rules at intake rather than after the fact.
- **Monitoring obligations after the first prescription** — In February 2025 the FDA issued class-wide labeling changes for testosterone products: the boxed warning on cardiovascular risk was revised in light of the TRAVERSE trial, and a new warning about blood pressure increases was added. Standard follow-up for a TRT patient therefore includes recheck testosterone, hematocrit, PSA where indicated and blood pressure. A program with no recheck workflow is not a clinic; it is a supply channel, and regulators treat it that way.
- **HRT for women and menopause programs** — Estradiol, progesterone and most menopause therapies are not controlled substances, so the DEA layer does not apply, but the same practice standards do: a licensed provider, a documented history including contraindications, an informed decision about route and dose, and a recheck plan. Compounded bioidentical products carry their own labeling and marketing limits. As of September 2026, FDA has been re-examining the class labeling for menopausal hormone therapy; your medical director should track that rather than rely on this page.
- **Marketing, corporate practice and the merchant of record** — Most states restrict who can own a medical practice and how a lay company can share in professional fees. MyOrbitHealth runs the managed-services structure so the licensed practice makes clinical decisions and your brand handles marketing, technology and patient acquisition. Your brand is the merchant of record and owns the patient relationship and data; there is no revenue share tied to prescribing volume, which is the arrangement that draws the most scrutiny in this category.

## What MyOrbitHealth runs for your TRT and hormone program

Everything below is live product, not a roadmap. A men's health brand that signs today typically launches in days, because the provider network, EPCS rails, pharmacy contracts and lab routing already exist and are configured to your brand rather than built for it.

- **Orbit Intake for hormone patients** — Branded questionnaires for low testosterone, andropause symptoms, perimenopause and menopause, plus identity verification and state detection. Intake captures the history a provider needs to rule out contraindications and flags anything that should stop a prescription before the visit is scheduled.
- **Orbit Labs, drawn three ways, for baseline and rechecks** — A provider orders the baseline panel. The patient collects it as a Quest or Labcorp walk-in with an order slip, a Tasso at-home kit shipped by FedEx, or a mobile phlebotomy visit. For the second morning draw the guideline expects, the same three options apply, which is what keeps completion rates up. Results route to the ordering provider, who reads them into the plan; the patient sees an interpreted result, not a raw PDF. Your storefront can also carry a patient self-order lab catalog for people who want a testosterone test at home before they commit to a visit.
- **Provider Network licensed in all 50 states** — 2,400+ board-certified MDs, DOs, NPs and PAs across 38+ specialties, credentialed to NCQA standards with monthly OIG and SAM screening, available 24 hours, with an average response under six minutes during business hours. Every prescriber who touches a controlled substance has completed EPCS identity proofing and holds a DEA registration.
- **OrbitRx with EPCS to 503A and retail pharmacies** — Prescriptions leave OrbitRx through Surescripts with EPCS two-factor sign-off. Testosterone cypionate and enanthate, gels, estradiol, progesterone, anastrozole, hCG where clinically appropriate and other ancillaries route to a LegitScript-certified 503A compounding or retail pharmacy, with cold chain for products that need it. Medication is passed through at 0% markup.
- **OrbitOS for the operator** — One console for encounters, orders, lab status, refills, recheck reminders and patient messages. Your team sees who is overdue for a recheck, which kits have not come back, which refills are waiting on a provider and where turnaround is slipping. Nothing clinical is editable by the brand; everything operational is visible.
- **Storefront, app and developer surface** — A branded storefront with checkout and subscriptions, a native iOS and Android app, and a REST API with webhooks and a React SDK for teams that want to keep their own front end. A public MCP server lets your internal tools query program state. Managed LegitScript certification for your brand is included: we prepare, file and manage the application through approval, typically days once filed, with the decision resting with LegitScript.

## Economics and where the program can go next

Hormone programs are subscription businesses with a long tail. The commercial terms below are the same for every brand, and the expansion paths are the ones our operators most often take once TRT or HRT is stable.

- **Platform fee:** A flat platform fee scoped at onboarding based on programs, states and volume. No per-prescription fee and no percentage of revenue.
- **Medication and labs:** Medication passes through at 0% markup. Lab pricing is quoted per program at onboarding; there is no published lab rate card.
- **Ownership:** The brand is merchant of record, owns the patients and the data, and can export both. No exit fee, month-to-month after onboarding.
- **Add men's health adjacent programs:** Erectile dysfunction, hair loss and weight management share the same intake and provider pool; most TRT brands add at least one within the first quarter.
- **Add HRT and menopause:** A TRT brand can open a women's hormone line on the same stack, with separate intake, separate product menu and the same lab and follow-up workflow.
- **Add longevity panels and peptides:** The self-order lab catalog and the 503A pharmacy network support longevity panels and legal, prescription-route peptide programs when the brand is ready.

## FAQ

### Can testosterone be prescribed by telehealth in 2026?
As of September 2026, yes. Testosterone is Schedule III, and the DEA and HHS extended the telemedicine flexibilities for controlled substances through December 31, 2026, allowing a DEA-registered practitioner to prescribe by audio-video visit without a prior in-person exam. The DEA has said a final rule is coming, so programs should be built to add an in-person or special-registration step if required. This is general information, not legal or medical advice.

### How many labs does a patient need before starting TRT?
AUA guidance calls for at least two early-morning total testosterone measurements on separate occasions, both below 300 ng/dL, together with symptoms or signs, before a testosterone deficiency diagnosis. Orbit Labs supports both draws through Quest or Labcorp walk-in, a Tasso at-home kit or mobile phlebotomy, and the ordering provider reads both results into the plan.

### Do you support a testosterone test at home?
Yes. A provider can order a Tasso at-home kit that ships to the patient and returns by FedEx, or a mobile phlebotomist can draw at the patient's home. Your storefront can also list a patient self-order lab catalog so someone can check their level before booking a visit. Lab pricing is quoted per program, not published.

### Does the platform handle HRT for women and menopause programs?
Yes. The same intake, provider network, OrbitRx and lab workflow run perimenopause and menopause programs built on estradiol, progesterone and related therapies, which are not controlled substances. Compounded products follow their own labeling rules, and your medical director sets the protocol.

### Which pharmacies fill TRT prescriptions?
Prescriptions route via Surescripts with EPCS to a LegitScript-certified network of 503A compounding and retail pharmacies, with cold chain where needed. Medication passes through at 0% markup and the brand remains merchant of record.

### What does an online TRT clinic cost to run on MyOrbitHealth?
There is a flat platform fee scoped at onboarding, no revenue share, no medication markup and no exit fee, with month-to-month terms after onboarding. We do not publish a figure because the scope depends on programs, states and volume; the number is fixed before you sign.

## Launch a TRT or hormone program the compliant way

EPCS-ready providers in all 50 states, two-draw baseline labs through Orbit Labs, LegitScript-certified pharmacy routing and a managed practice structure, all under your brand and live in days.

Book a call: https://myorbithealth.com/book

Go deeper: [how to launch an online TRT clinic](https://myorbithealth.com/blog/how-to-launch-online-trt-clinic), [what an online TRT clinic needs](https://myorbithealth.com/blog/online-trt-clinic), [starting a men's health brand](https://myorbithealth.com/blog/start-mens-health-brand), [telehealth prescribing rules for 2026](https://myorbithealth.com/blog/telehealth-prescribing-rules-2026)